Analysts Offer Predictions for Gilead Sciences Q2 Earnings
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research raised their Q2 2026 EPS estimates for Gilead Sciences in a research note issued on Friday, April 4th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will earn $1.84 per share for the quarter, up from their prior forecast […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research raised their Q2 2026 EPS estimates for Gilead Sciences in a research note issued on Friday, April 4th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will earn $1.84 per share for the quarter, up from their prior forecast […]
